With the rise of digital health and novel health technologies, changing payment models, and plateauing health outcomes there is a pressing need for healthcare to adapt and select a new path forward.
At Strategy Health we often hear that most health systems and digital health firms stumble at the first hurdle. How do you effectively navigate a shifting digital health landscape and focus on what truly delivers outcomes? This is where Strategy Health offers a unique perspective, helping to filter through the noise and focus on providing digital strategies that deliver long-term performance and growth.
Dr. Shrawan Patel, MD is a recognised voice in the digital health ecosystem with expertise ranging from digital therapeutics and successful patient engagement techniques, through to digital infrastructure design for pharmaceutical Medical Affairs teams. With a clinical background that includes Internal Medicine and General/Colorectal Surgery, Shrawan brings a wealth of clinical experience to the table.
Shrawan has a particular interest in the application of Behavioural Economics in healthcare with proven outcomes that exceed the industry norm and have been recognized by national associations including the American College of Radiology, American Gastroenterology Association, and the American Medical Informatics Association. Shrawan speaks regularly around the country on innovation and digital health.
Dr. Melody Burgo, MD, MHA is a trained physician with an interest in dermatology and cutaneous oncology who has an extensive background in translational research, life sciences, and digital health. She has successfully brought innovative technologies into healthcare, including projects with Roche and Takeda Pharmaceutics.
Melody is an expert in operationalizing digital strategies and fostering interrelationships between providers, life sciences, and health-technology firms. Her strengths lie in crafting strategic plans for successful digital transformation and go-to-market action plans that meet the requirements of all stakeholders involved.
Elizabeth Otter, MPH has an extensive background working with hospital CEOs, physician executives, and digital health founders to solve complex problems. Formerly Director of Innovation Development at the American College of Cardiology (ACC) she was key in developing the College’s long-term innovation strategy, product development, and building partnerships with digital health, AI, and precision medicine firms.
Previously she served as Director of Care Variation & Performance Technologies at The Advisory Board Company (now part of Optum) and most recently a member of Russell Reynolds Associates’ (RRA) Health Care Services Practice. Elizabeth has a passion for utilizing her broad skillset to work through complex digital health product and commercial strategies to help drive sustainable growth and achieve the quadruple aim.